Healthcare Industry News CSR News

The Impact of COVID-19 on a Company: 6 Questions for the Chief Financial Officer of Johnson & Johnson

By Liz Ozaist, Global Content Lab Editor-in-Chief, Johnson & Johnson
Summary: 

When you're the CFO of a company, you have a holistic view of how a pandemic can touch every aspect of a business, especially when it's a healthcare company. So we posed inquiring mind questions to Joe Wolk about what the past eight months have been like for him at the financial helm of the company—via a Zoom interview.

Blog

When you're the CFO of a company, you have a holistic view of how a pandemic can touch every aspect of a business, especially when it's a healthcare company. So we posed inquiring mind questions to Joe Wolk about what the past eight months have been like for him at the financial helm of the company—via a Zoom interview.

CRB's SlateXpace™ Gives Cell and Gene Therapy Clients New Flexibility, Control Over Manufacturing Needs To Support Highly Complex Product Pipelines

CRB, a leader in the design and construction of biotech manufacturing facilities, creates SlateXpace – a multimodal facility solution that delivers unmatched industry speed, flexibility and adaptability for the advanced therapy market
Press Release

SAN DIEGO, Calif., Sept. 30, 2020 /3BL Media/ – Emerging health threats, uncured diseases and the need to deliver critical therapies to patients are driving biotech companies to search for ways to build flexibility into their complex product pipelines and deliver projects in record time. Today, a pioneering multi-modality manufacturing solution addresses that challenge: SlateXpace™.

Johnson & Johnson Initiates Pivotal Global Phase 3 Clinical Trial of Janssen's COVID-19 Vaccine Candidate

First participants dosed in Phase 3 trial (ENSEMBLE) evaluating safety and efficacy of Janssen’s COVID-19 vaccine candidate, JNJ-78436735, also known as Ad26.COV2.S
Press Release

NEW BRUNSWICK, N.J., September 28, 2020 – Johnson & Johnson (NYSE: JNJ) (the Company) recently announced the launch of its large-scale, pivotal, multi-country Phase 3 trial (ENSEMBLE) for its COVID-19 vaccine candidate, JNJ-78436735, being developed by its Janssen Pharmaceutical Companies. The initiation of the ENSEMBLE trial follows positive interim results from the Company’s Phase 1/2a clinical study, which demonstrated that the safety profile and immunogenicity after a single vaccination were supportive of further development.

The Next Phase of Our COVID-19 Vaccine Development

by Alex Gorsky Chairman of the Board and Chief Executive Officer, Johnson & Johnson
Blog

It’s hard to believe that just six months have passed since our scientists identified Janssen’s lead COVID-19 vaccine candidate. We couldn’t have predicted all the changes that have happened since. Two things, however, have been constant: COVID-19 continues to be a devastating pandemic, and Johnson & Johnson has been working around the clock on a potential solution.

The Road to a Vaccine, Season 2, Ep. 7: Is It Really Safe for Schools to Be Open Right Now?

Multimedia with summary

In Season 2 of "The Road to a Vaccine," host Lisa Ling interviews scientists, global health leaders and other experts on the COVID-19 front lines to reveal the latest medical advances and collaborations to create a coronavirus vaccine—and hopefully a return to a world without the pandemic.

As schools reopen—and sometimes close again—what have we learned about the risks of in-person learning? Lisa Ling speaks to school nurse Robin Cogan and pediatrician Dr. Sam Maldonado to find answers and debunk myths around kids and COVID-19.

The Ohio State University Wexner Medical Center Joins Healthcare Facility Advisory Board

Press Release

September 18, 2020 /3BL Media/ - The Healthcare Plastics Recycling Council (HPRC) is pleased to announce the appointment of The Ohio State University Wexner Medical Center to its Healthcare Facility Advisory Board (HFAB), a role intended to help the council set priorities and steer the agenda toward its mission of inspiring and enabling sustainable, cost-effective recycling solutions for plastic products and materials used in the delivery of healthcare.

Medtronic: Quality Care, From Anywhere

With a global pandemic still raging in parts of the world, Medtronic is helping stretched-thin clinicians work quickly, safely, and efficiently with the help of remote technology.
Article

When the COVID-19 crisis was hitting its apex in New York earlier this year, doctors needed a way to remotely monitor the vital signs of patients admitted to a large convention center that had been converted into a field hospital.

So, a team from Medtronic quickly installed several of the company’s technologies to create a system that allowed about 10 clinicians to remotely monitor about 400 patients at the Jacob K. Javits Convention Center.

Getting such an operation up and running normally takes weeks or months … Medtronic did it over a weekend.

Medtronic: The Doctor Will See You Now, Please

What hospitals do and say over the next few months isn’t just about optics.
Article

THE PANDEMIC PARADOX

Medical Electronic Devices Are Facing a Critical Test

By Huei Sin | VP of General Electronics Measurement Solutions and VP of Keysight Education, Keysight Technologies Inc.
Article

The market for medical electronics today represents a comparatively small share of the nation’s nearly $200 billion in overall health expenses – about 5.2% in 2019. But the value it brings to the practice of medicine is disproportionately large and growing rapidly. As a result, the medical electronics industry is expected to see significant growth, propelled by the rising incidence of chronic disease coupled with greater use of medical imaging, monitoring and implantable devices – all combined with an increasingly elderly population.

Johnson & Johnson Signs a Historic Pledge to Uphold the Integrity of the Scientific Process in Developing an Investigational COVID-19 Vaccine

In signing the pledge, we are joining eight other biopharmaceutical companies working on vaccine research and development in making the safety and well-being of vaccinated individuals our top priority.
Article

Recently, Johnson & Johnson announced that we, alongside eight other companies working on investigational COVID-19 vaccines, are signing a #WeStandWithScience pledge committed to upholding the integrity of the scientific process as we work towards potential global regulatory filings and approvals of the first vaccines for COVID-19.

Pages

Subscribe to Healthcare Industry News